C-UPKCRION
platelet-derived exosomes, PEP, drug delivery
repairingextracellular vesicle
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-UPKC
C-UPKCC-UPKCplatelet-derived exosomes, PEP, drug delivery
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Does ( plated ) prove they have exosomes? How does ( plated ) prove it? Do exosomes need to be frozen to actually work? Dr. Behfar, co-founder of RION and world renowned regenerative science expert, breaks down one of the biggest misconceptions in skincare—and explains what makes this exosome product truly legitimate and what providers and consumers should look for to evaluate exosome products. Drawing from over two decades of published research on platelet-derived exosomes, Dr. Behfar shares how scientific rigor, mechanistic studies, and characterization help validate whether a product truly contains intact, functional exosomes. About ( plated ): A science-forward beauty brand and the first to harness platelet-derived exosomes. Doctor-founded and inspired by regenerative science, ( plated ) is renewing the appearance of hair and skin through clinical innovation. Watch to learn: • Why intact exosomes can remain stable at room and body temperature • Why some products require freezi
In this episode of The BioHub Podcast, Max sits down with Dr. Atta Behfar, Co-Founder of Rion and Professor of Regenerative Medicine at Mayo Clinic. Atta’s work at Mayo led to a key discovery that became the foundation for Rion, a clinical-stage company developing exosome-based therapeutics through its Purified Exosome Product (PEP) platform. In this conversation, Atta shares the story behind that discovery, how it translated into a company, and the potential of cell-free regenerative medicine to make advanced biologics more accessible to patients. We also discuss Rion’s progress in wound healing, how the team has been built, and what’s next for their pipeline. A fascinating look at how breakthrough science becomes real therapies.
Exosomes are everywhere in the regenerative world right now, but not all exosomes are the same. In this episode, Dr. Kara Fitzgerald sits down with Alisa Lask, CEO of Plated Skin, to explore the science behind platelet-derived exosomes and why their signaling pathways matter for skin appearance, cellular repair, and overall tissue support. You’ll learn how discoveries in cardiology shaped this emerging field, what early studies show about collagen and redness, and why source, preparation, and delivery are critical in evaluating any exosome-based product. We also discuss how clinicians can navigate a rapidly growing landscape where “exosomes” are often marketed without meaningful scientific backing. If you're curious about the real mechanisms behind repair, renewal, and regenerative aesthetics and how platelet-derived exosomes differ from other forms, this conversation offers rare clarity. 🔗 Full show notes + references: https://www.drkarafitzgerald.com/fxmed-podcast/ *GUEST DETAI
Rion is developing platelet-derived exosome therapeutics as off-the-shelf, room-temperature-stable alternatives to traditional cell therapies. The company’s lead program is advancing toward phase 3 trials in diabetic foot ulcers, and it is building a broader pipeline across musculoskeletal, cardiovascular, pulmonary, dermatologic, and women’s health indications. The company is built on stem cell research conducted at the Mayo Clinic that showed that regenerative benefits from treatments stemmed from exosome-mediated biological signaling that promoted healing rather than from transplanted stem cells themselves. We spoke to Atta Behfar, co-founder and CEO of RION, about how the company’s purified exosome products work, their potential as scalable, cost-effective regenerative therapies, and how they avoid the immune issues that have long hampered cell-based approaches.
The goal of this clinical trial is to learn if drug Purified Exosome Product (PEP™) and Fibrin Sealant (TISSEEL® VH SD Kit) (PEP-TISSEEL) works to treat chronic radiation ulcer in adults and compare it with comparator TISSEEL. It will also learn about the safety of drug PEP-TISSEEL.
Evaluate the safety and exploratory efficacy of single intra-articular injections of PEP reconstituted with 0.9% Normal Saline at a low dose (one vial PEP) and high dose (two vials PEP), with and without EUFLEXXA, for the treatment of Knee Osteoarthritis
This is a Phase 2a Multi-Center, Prospective, Randomized, Controlled Study aimed to evaluate the Safety and Efficacy of Topically Applied PEP-TISSEEL in Subjects with Diabetic Foot Ulcers (DFU)
In this video, Atta Behfar, M.D., Ph.D., Founder of Rion, Inc., discusses why platelets are the best source of exosomes, the origination of Renewosome™ technology. Explore how mesenchymal stem cells facilitate tissue renewal while platelet-derived cues drive skin rejuvenation through potent antioxidants. Join us on this journey into regenerative medicine's science and the extraordinary role of platelets. Visit us: https://www.rionaesthetics.com/ Follow: https://www.instagram.com/rionaesthetics/ https://www.linkedin.com/company/rion-aesthetics/ Share this video: https://youtu.be/exdj5kd1Ots
This may be our most fascinating podcast ever! We are joined by the Co-Founder of Rion, Inc., researcher and pioneer of regenerative medicine, and Cardiologist at the Mayo Clinic, Atta Behfar, MD, PhD. We're also joined by Saranya Wyles, MD, PhD, Associate Professor of Dermatology, Program Director of Clinical Regenerative Medicine Education at Mayo Clinic and the Principle Investigator for Rion Aesthetic's flagship product, (plated)™. Dr. Behfar spent several years in the initial stages of research getting a deep understanding of what influences cells to participate in wound healing. His research led him to find the major gap- communication- which is where exosomes come into play. They are the mechanism by which cells communicate with one another and make things happen in the body. Next, it was about finding the best communicators which led him and his research team to identify a particular group of platelet-derived exosomes that were specifically communicating about regeneration a
JOIN us at our next Aesthetics Innovation Summit: https://bit.ly/3MdSAru WEBSITE https://attendais.com FOLLOW Aesthetics Innovation Summit On Social Media: ► LinkedIn: https://www.linkedin.com/company/attendais ► Instagram: https://instagram.com/AIS_Summit JOIN Our Group For Aesthetics Innovation & Investment On LinkedIn https://www.linkedin.com/groups/12089660/ #AIS #Aesthetics #Healthcare _ About AIS The Aesthetics Innovation Summit (AIS), produced by Healthegy Inc., unites the clinical, corporate and capital leaders to facilitate the exchange of insights on emerging trends while showcasing exciting new drugs, devices, and technologies for the aesthetics market which is projected to double by 2025.
"A lot of what's happening in the world of industry and aesthetics happens here." Welcome to the Aesthetics Innovation Summit in San Diego, where that quote from Dr. Steve Dayan has never been more true. For while "innovation" as a word can tend toward overuse, at AIS we find factual transformation and metamorphosis in the most creative and novel developments the aesthetic industry has to offer. In this extended episode, recorded live at AIS, Dr. Grant Stevens interviews over a dozen of the biggest movers and shakers in the beauty business to take us through a window into the future of aesthetics itself. So sit down and strap in for an absolutely earth-shaking episode of the Technology of Beauty. Featured guests include: 00:01:04 Carrie Caulkins – Galderma 00:04:23 Jordan Schindler - Nufabrx 00:08:52 Dr. Steven Dayan 00:14:48 Dennis Condon - Suneva 00:19:10 William Meury - Hildred Capital 00:26:16 Alisa Lask – Rion 00:30:20 Aaron Burton - Sciton 00:38:35 Saranya P. Wyles, M.D., Ph.D
Dr. Atta Behfar presenting Rion LLC. Level: Professional
On this week’s episode of Beauty Bytes, I am talking all about regenerative medicine and exosomes with transplant cardiologist Dr. Atta Behfar. Dr. Behfar received his M.D. from the Mayo Clinic School of Medicine and a Ph.D. in stem cell biology and molecular pharmacology and therapeutics from the Mayo Clinic Graduate School of Biomedical Sciences. He gives us an insider look into his cutting-edge research on exosomes, their function, and possible benefits. Exciting results have been coming out of the Mayo Clinic and his company, RION, in the clinical application of exosomes for cardiovascular injuries, wound healing, orthopedics, and anti-aging. Could exosomes be the next foundational pillar in skincare? Listen on to find out more! Check out Rion! riontx.com Follow me on Instagram! https://instagram.com/beautybydrkay Check out my skincare! https://beautybydrkay.com/store/ #cardiologist #doctors #medicine #exosomes #medical #schoolofmedicine #mayoclinic
Atta Behfar, M.D., Ph.D., CEO Rochester, MN (Private)
The purpose of this study is to determine the safety of a biological therapeutic PEP in participants who have skin graft donor site wounds.
Rion Roseborough - Football - East Carolina University Athletics Skip to main content Pause All Rotators All Rotators Playing East Carolina University Skip Ad Close Ad Skip Ad Search Search Toggle Main Navigation Schedule , Opens in new window Tickets , Opens in new window Pirate Club , Opens in new window Shop , Opens in new window Teams Baseball Basketball (M) Basketball (W) Cross Country Football Golf (M) Golf (W) Lacrosse Soccer Softball Swimming/Diving (W) Tennis (W) Track & Field Volleyball Skip Ad Department Departments Athletic Training Compliance Life Skills Spirit Sponsorship Opp
#studentsponsorship #rionequipment #futureleaders #dieseltechnology #careeropportunities #mentorshipmatters #buildyourfuture #rioncommunity #nextgenleaders #dieseltech #industryinnovators… | Rion Equipment LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time … iesel technology. If you’re passionate about diesel engines and eager to learn, apply today and take the first step towards a bright future with Rion Equipment. Together, we can build the skills and knowledge that drive the industry forward. 🚀 Learn more about the program and apply today! https://lnkd.in/emzxtnXk #StudentSponsorship #RionEquipment #FutureLeaders #DieselTechnology #CareerOpportunities #MentorshipMatters #BuildYourFuture #RionCommunity #NextGenLeaders #DieselT
%PDF-1.3 %��������� 4 0 obj > stream x�}ْd���{|�5�l�2#�b_�/S�D��ER&�1�$����̥��E�?�p?w ����L6 ����XݏÁ���{�S�Z6 n��l�\6��j���67ͳ��g͋�f�� n��n����"{f���n�\b� �l7���s|� ��_�Xg��Ȱ.}����V�$u������]`kٝ-V�l>�� �^�pZ3�K7���r��#K�2�f]�.�� ]��e�Ȓ��_fm֥ ����n���#K�2�N����a7��P �I��'�,�Z��3�7,OYX����Z�z��r5 {�n"X&SD�U� ��v1̷f�"�LYW����#��)b� SD�UD�',�n"��n1cߵ�GejO�a(�U2d`%��AĒhmejOP;�yړ���m k�JP����VRM�-�EPD�ꂘlG�����Y�2�'6F���j�g��TGZ E�n�D,�0ӣ�iM�LY7C�]�����j�e�^W�� b*�!�f� �wz"ZIE4��H�����m��v�Gf�6�f���sd�d�1���TGZ E��V[Im���u3D�Չh%�d��UD�ꂘJf��Y7Ct{b����j�Gf�6
RION-ENG-vol14 RION-ENG-vol14 18/24 The Deaflympics is the Olympic Games for athletes who are deaf or hard of hearing. It’s held every four years, with both summer and winter games.BirdCLEF+ 2025 was an international compe-tition event held on Kaggle, the world’s largest data analysis competition platform.Masatoshi Osawa (left) and Ryo Sato (right)BirdCLEF+ 2025, held from March 10 to June 5, 2025, challenged participants to use AI to identify the species of various animals from audio recordings of their calls made in the El Silencio Natural Reserve in Colom-bia. Out of 2,025 participating tea … nstitute of Noise Control Engineering of Japan[Online meeting, April 17, 2025]• Application of Monitoring System for Long-Term On-Site Measurement of Low-Frequency Sound ProblemMinori Dan, Tomoaki Cho, Ryosuke Kazama, and Tetsuya Ozaki (Rion)● Acoustical Science and Technology[Acoustical Society of Japan, date of issue: July 1, 2025]• Application of machine learning in aircraft noise monitoring: Determining disturbance sounds within aircraft noise eventsTsumugi Nakayama (Rion
Careers – RION Jewelry Your cart Close cart Your cart is currently empty. Subtotal €0,00 €0,00 Taxes and shipping calculated at checkout Checkout     FREE SHIPPING ON DOMESTIC ORDERS OVER $100 : FREESHIP100 Search Country/region Australia (AUD $) Austria (EUR €) Belgium (EUR €) Canada (CAD $) Czechia (CZK Kč) Denmark (DKK kr.) Finland (EUR €) France (EUR €) Germany (EUR €) Hong Kong SAR (HKD $) Ireland (EUR €) Israel (ILS ₪) Italy (EUR €) Japan (JPY ¥) Malaysia (MYR RM) Netherlands (EUR €) New Zealand (NZD $) Norway (USD $) Poland (PLN zł) Portugal (EUR €) Singapore (SGD $) South
Corp - Rion Evans Rion Evans HOME BIO & CREDITS EVENTS Comedy Acting RE Merchandise NEWS REP Comedy Night REP Game Show Night GALLERY CONTACT HOME BIO & CREDITS EVENTS Comedy Acting RE Merchandise NEWS REP Comedy Night REP Game Show Night GALLERY CONTACT Rion Evans Presents events are a fun and hilarious night out for you and your friends and family with the best host in town guiding the way! Rion Evans is a 20 year professional comedian with multiple television appearances and has hosted countless important events from comedy shows to huge corporate award ceremonies … sional stand up Comedy Show and also a TV Game Show event with our Master Host, award winning actor and producer, Comedian Rion Evans, who has 20 years of entertainment experience and multiple television appearances. Our TV Game Show along with our Comedy events are featured in multiple venues throughout Colorado. We are currently booking corporate events and want to increase our corporate presence. We're reaching out to your company to offer one or both of these … s, projector, projection screen, table runners, lights, sound and prizes and an Award Winning Master Host that has more than 20 years of entertainment experience. We're currently in 6 venues and counting throughout Colorado and regularly book Corporate events both in person and virtually. Our vision is to do huge tournament style competitions throughout the state, including college tournaments, celebrities and local media outlets battling it out for a local non-pr
Rion Equipment - We are excited to welcome Kasen to the... Facebook Log In Rion Equipment's Post Rion Equipment March 10 · Shared with Public We are excited to welcome Kasen to the Rion Equipment Diesel Tech Sponsorship Program. Kasen is a graduate of Millard South High School and will be gaining hands-on experience at our Omaha dealership. He will also be attending Iowa Western Community College as he begins his journey in the diesel technology field. We are proud to support students like Kasen as they build their careers in the industry. Welcome to the team, Kasen! #RionEquipment #Diese
The Eric Rion Addiction Scholarship Fund — New Directions of Horry County 0 Skip to Content Donate to New Directions Our Story Who We Are Board of Directors 10th Annual Compassion Through Fashion Volunteer About New Directions Partners Photo Galleries Compassion Through Fashion 2026 Sponsorship Guide News Events What We Do FAQ Programs & Services Success Stories Eric Rion Addiction Scholarship Fund Compassion Through Fashion Watch CTF 2024 CTF News & Updates CTF 26 Vote Get Involved How to Help Current Needs Tour Compassion Through Fashion Info Need Help? Donate Open Menu Close M … ents What We Do FAQ Programs & Services Success Stories Eric Rion Addiction Scholarship Fund Compassion Through Fashion Watch CTF 2024 CTF News & Updates CTF 26 Vote Get Involved How to Help Current Needs Tour Compassion Through Fashion Info Need Help? Donate Open Menu Close Menu Donate to New Directions Our Story Folder: Who We Are Back Board of Directors 10th Annual Compassion Through Fashion Volunteer About New Directions Partners Photo Galleries Compassion Through … What We Do Back FAQ Programs & Services Success Stories Eric Rion Addiction Scholarship Fund Folder: Compassion Through Fashion Back Watch CTF 2024 CTF News & Updates CTF 26 Vote Folder: Get Involved Back How to Help Current Needs Tour Compassion Through Fashion Info Need Help? Donate Eric Rion Addiction Scholarship Fund The Eric Rion Addiction Scholarship Fund provides the opportunity for those suffering from addiction to receive the help they need through scholarshi … ip into recovery programs where they will have the best chance of success. This fund is in memory of Eric Rion who passed away on February 28, 2023. Eric was a close friend of our Program Director, William Howsare, and together, they shared a passion for helping people experience recovery. The Rion Family, Smith Family, and William Howsare established this fund to keep Eric’s memory alive and to continue helping those struggling with addiction just as he had done. His family … e on through the lives that are changed thanks to the recovery provided by this scholarship fund. Eric P. Rion November 26, 1987 - February 28, 2023 Give Now New Directions of Horry County 1005 Osceola Street Myrtle Beach, SC 29577 (843) 945-4902 Mailing Address P.O. Box 2922, Myrtle Beach, SC 29578 Who We Are About New Directions Our Story Board
Careers – RION Jewelry Your cart Close cart Your cart is currently empty. Subtotal €0,00 €0,00 Taxes and shipping calculated at checkout Checkout     FREE SHIPPING ON DOMESTIC ORDERS OVER $100 : FREESHIP100 Search Country/region Australia (AUD $) Austria (EUR €) Belgium (EUR €) Canada (CAD $) Czechia (CZK Kč) Denmark (DKK kr.) Finland (EUR €) France (EUR €) Germany (EUR €) Hong Kong SAR (HKD $) Ireland (EUR €) Israel (ILS ₪) Italy (EUR €) Japan (JPY ¥) Malaysia (MYR RM) Netherlands (EUR €) New Zealand (NZD $) Norway (USD $) Poland (PLN zł) Portugal (EUR €) Singapore (SGD $) South
Careers at Rion Inc. Careers at Rion Inc. Our Current Job Openings Type All Types Full-time Location All Locations Rion offices Role Type Location Director of Facilities and Engineering Full-time Rion offices © 2014-2026 TriNet Group, Inc. All rights reserved. Privacy Policy
Careers – RION Jewelry Your cart Close cart Your cart is currently empty. Subtotal €0,00 €0,00 Taxes and shipping calculated at checkout Checkout     FREE SHIPPING ON DOMESTIC ORDERS OVER $100 : FREESHIP100 Search Country/region Australia (AUD $) Austria (EUR €) Belgium (EUR €) Canada (CAD $) Czechia (CZK Kč) Denmark (DKK kr.) Finland (EUR €) France (EUR €) Germany (EUR €) Hong Kong SAR (HKD $) Ireland (EUR €) Israel (ILS ₪) Italy (EUR €) Japan (JPY ¥) Malaysia (MYR RM) Netherlands (EUR €) New Zealand (NZD $) Norway (USD $) Poland (PLN zł) Portugal (EUR €) Singapore (SGD $) South
Careers at RION Equipment | Material Handling Skip to content 866-330-RION LOCATION EQUIPMENT PARTS & SERVICES Parts Service Industrial Supplies SUPPORT Financing Fleet Management Warehouse Analysis Warranty Protection Plan MANUFACTURERS CAT Lift Trucks Mitsubishi Jungheinrich Shuttlewagon Taylor Terberg Hawker Princeton ABOUT Why Us Careers Locations CONTACT US SEARCH LOCATION 866-330-RION Facebook Icon Linkedin Icon EQUIPMENT PARTS & SERVICES Parts Service Industrial Supplies SUPPORT Financing Fleet Management Warehouse Analysis Warranty Protection Plan MANUFACTURERS CAT Lift Truck
Jobs at Rion Inc. - Medical Alley Jobs Organizations Talent Job seekers Log in Sign up Employers Log in Sign up Post a job Menu Close Jobs Organizations Talent Post a job Jobs at Rion Inc. Heal From Within. View profile Website Linkedin Overview Photos Read more New jobs {{total_jobs_count}} {{pagination_label}} {{filters_labels.sortby}} Sort By Newest Salary Random Apply filters 0">Clear all filters Keywords 0 || remote_only_count > 0 || location_filter_set || remote_filter_set || remoteonly_filter_set"> Location {{location}} Filter by location... 0" class="clear-btn" @click="clearLocations($
RION to showcase groundbreaking exosome technology at J.P. Morgan Healthcare Conference - Exosome RNA --> Don't Miss ’Footprint of Death’ gives new clues to cell life Positive CAR-exosome in vitro tumour killing demonstrated in ovarian cancer cells UC San Diego Researchers Receive ARPA-H Award to Make Birth Safer iMSC-derived extracellular vesicles may offer a new approach for osteoarthritis treatment Maternal weight may influence microbiota signalling in amniotic fluid SECmeres outperform extracellular vesicles as potential blood RNA biomarkers for Alzheimer’s disease Quantification of EV-ass … ated in ovarian cancer cells 2 days ago UC San Diego Researchers Receive ARPA-H Award to Make Birth Safer 3 days ago iMSC-derived extracellular vesicles may offer a new approach for osteoarthritis treatment 3 days ago Maternal weight may influence microbiota signalling in amniotic fluid 4 days ago SECmeres outperform extracellular vesicles as potential blood RNA biomarkers for Alzheimer’s disease 4 days ago Social Networking Pages Exosome RNA 3,188 Followers 123 Fans © Copyri
RION | MTEC MTEC Focus Areas Who we serve Solicitations Patents About Us Explore Join MTEC Log In Members / Member 1 Award RION RION is a clinical-stage regenerative medicine company based in Rochester, MN, focused on revolutionizing exosome science to heal from within. Established in 2017, RION leverages the unique properties of exosomes derived from platelets to develop innovative therapies aimed at enhancing tissue regeneration and addressing various medical challenges. Industries biopharma biotechnology Nr. of Employees small (1-50) RION Contact Information Company 202 4th Street SW, Suite … tment of Achilles Tendinopathy (Clinical Trial) Funding (ceiling) $ 2,576,446.7 Award Year 2024 Patents Particle measuring device 2025-04-01 • US-12265008-B2 View Details Particle measuring device and particle measuring method 2024-12-31 • US-12181398-B2 View Details Particle measuring device, calibration method, and measuring device 2023-10-03 • US-11774340-B2 View Details Microbial particle measuring apparatus and microbial particle measuring method 2022-10-18 • US-11474017 … ions View All People Show less News & Updates RION Awarded the Entrepreneur Award at the 11th Annual R.A.V.E RION received recognition for its innovative contributions to the field of regenerative medicine. RION Expands Leadership Team with the Appointment of Five Renowned Experts to Advisory Boards RION has strengthened its leadership team by appointing five experts to its advisory boards. RION Announces Initiation of Phase 1b Clinical Study to Evaluate Purified Exosome
Episode 150 - Dr Atta Behfar -…–The BioHub - by Avetix – Apple Podcasts Search Home New Top Charts Search 16 April 30 min Episode 150 - Dr Atta Behfar - Founder of Rion The BioHub - by Avetix Play In this episode of The BioHub Podcast , Max sits down with Dr. Atta Behfar, Co-Founder of Rion and Professor of Regenerative Medicine at Mayo Clinic. Atta’s work at Mayo led to a key discovery that became the foundation for Rion, a clinical-stage company developing exosome-based therapeutics through its Purified Exosome Product (PEP) platform. In this conversation, Atta shares the story behind that d
Researching regenerative medicine in war zones - Government & Policy - HIMSS TV Homepage HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare. Home Browse Video Categories Search Videos toggle navigation Home Enter terms to search videos Perform search Latest Videos HIMSS TV @ HIMSS26 HIMSS26 Changemaker Awards HIMSS TV @ HIMSS25 HIMSS25 Changemaker Awards HIMSS TV @ HIMSS24 HIMSS24 Changemaker Awards HIMSS TV @ HIMSS23 HIMSS23 Changemak … yo Clinic and the U.S. Army Medical Research Institute thanks to a $2.4 million grant from the DoD to study Rion's Exosome Product for service members. Read More Read Less Government & Policy - Similar Videos View more in Government & Policy 6:01 Why TEFCA needs a centralized governance model Fragmented identifiers in healthcare and a federated governance model can inhibit trusted access, explains Patrick Lane, president and COO of Health Gorilla. Why TEFCA needs
Chairman Rion Ventures Pvt. Ltd. Health Professional American Society of Clinical Oncology USA | Don Roy Terrence Opatha LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join o
Research Associate, Analytical Development in Rochester at Rion | Apply now! – StudySmarter – Talents Everything for your career Find a job Research Associate, Analytical Development in Rochester Apply Now Apply Now Job Board Companies Rion Research Associate, Analytical Development Research Associate, Analytical Development in Rochester Rochester Full-Time 43200 - 72000 $ / year (est.) No home office possible Apply Now Apply Now R At a Glance Tasks: Contribute to innovative research in exosome technology and execute experiments in a dynamic lab environment. Company: Join Rion, a cutting-edge … haring your experiences on platforms like ResearchGate to enhance visibility. ✨ Apply Directly On Company Websites When you find a company you're excited about, like Rion, go directly to their careers page and apply. Many biotech firms prefer to source candidates from their own sites. Also, it shows initiative and that you’re serious about joining the team! We think you need these skills to ace Research Associate, Analytical Development in Rochester Analytical Method Deve … nication Skills Organizational Skills Problem-Solving Skills Some tips for your application 🫡 Showcase Your Scientific Skills: When applying for a full-time role in biotechnology, it's crucial to highlight your relevant scientific skills and experience. Include specific techniques or technologies you've worked with, like CRISPR or mass spectrometry, in your CV. This way, we can see that you have the hands-on experience necessary for the position at Rion. Tailor Your … ring cross-functional team initiatives. This can make a huge difference in your application quality. How to prepare for a job interview at Rion ✨ Showcase Your Technical Know-How In biotechnology, it's crucial to demonstrate a strong grasp of relevant techniques and tools—so be prepared to discuss the lab methods you've used or any specific projects you’ve been part of. Bring along any data or results that highlight your contributions; we want to see how you can apply … esearch Associate, Analytical Development in Rochester Rion Location: Rochester Apply Now Apply Now Company Login About Us Product Exams Explanations Magazine Help Help Center Premium Login © Vaia Terms Privacy
Official Series Description - RION Series LOCATION RION SC+GA NC VA Established Series Rev. RLV:DJD: RHB 05/2006 RION SERIES The Rion series consists of very deep, well drained, moderately permeable soils that formed in material mostly weathered from acid crystalline rocks of the Piedmont Uplands. Slopes commonly are 15 to 25 percent but range from 2 to 60 percent. TAXONOMIC CLASS: Fine-loamy, mixed, semiactive, thermic Typic Hapludults TYPICAL PEDON: Rion loamy sand on a 20 percent slope with a southern aspect; recently planted pines. (Colors are for moist soil unless otherwise stated.) A --0
%PDF-1.3 %���� 12 0 obj > endobj xref 12 20 0000000016 00000 n 0000000912 00000 n 0000000974 00000 n 0000001271 00000 n 0000001400 00000 n 0000001491 00000 n 0000002278 00000 n 0000002367 00000 n 0000003118 00000 n 0000003821 00000 n 0000004509 00000 n 0000005189 00000 n 0000005836 00000 n 0000006528 00000 n 0000007200 00000 n 0000007859 00000 n 0000008080 00000 n 0000008251 00000 n 0000010110 00000 n 0000000696 00000 n trailer ]/Prev 247485>> startxref 0 %%EOF 31 0 obj >stream h�b```a``�$+@����(�qa�4�;@&�%3�30Ht0�v4�����y��bQ�H���� �� ��s�"�0(}�,`�`�;�������{P���� … bj > endobj 7 0 obj > endobj 8 0 obj > endobj 9 0 obj > endobj 10 0 obj >stream application/pdf Image 2014-08-06T17:57:21-05:00 Canon iR C3480 2014-08-08T12:28:20-04:00 2014-08-08T12:28:20-04:00 Adobe Acrobat 9.0 Paper Capture Plug-in uuid:9c3b879d-0056-2944-bebc-acfce2f1b112 uuid:7b4e9a65-f499-8e44-af7d-2296e254feff endstream endobj 11 0 obj > endobj xref 0 12 0000000000 65535 f 0000146356 00000 n 0000146608 00000 n 0000148913 00000 n 0000150771 00000 n 0000242948 00000 n 00
RION MOLECULAR | Regulated Active Ingredients RION MOLECULAR Our Focus Capabilities Markets Partnership Contact Regulated Active Ingredient Platform Manufacturing and Regulatory Execution for High-Compliance Chemistries EPA-registered manufacturing-use products and technical support for downstream formulation programs. Request Technical Discussion Our Focus Quaternary Ammonium Chloride Active Ingredient Platform RION Molecular operates a regulatory-governed manufacturing platform centered on quaternary ammonium chloride active ingredients. Our portfolio is structured around EPA-registered manu … beling review Technical Integration Formulation support for EUP developers with application-specific guidance. EUP formulation support Compatibility guidance Concentration optimization Technical documentation Markets Served High-Compliance Application Sectors RION Molecular supports regulated active ingredient supply across sectors where documentation integrity, concentration governance, and regulatory alignment are essential. Household & Institutional Hygiene Programs Struct … llaboration For EUP development programs requiring formulation optimization and application-specific guidance. Portfolio Expansion Additional regulated active ingredients are under technical and regulatory evaluation. Technical Inquiry For regulatory discussions, sub-registration pathway inquiries, or technical integration questions, submit your request below. RION Molecular, LLC 4400 N. Scottsdale Road, Suite 9252 Scottsdale, AZ 85251 Name Company Email Inquiry Type Select.. … ct... Direct Procurement Sub-Registration Technical Collaboration Other Message Submit Inquiry RION MOLECULAR Products are sold in accordance with applicable regulations and approved labeling. © 2026 RION Molecular, LLC
RION engages Lonza to scale manufacturing exosome based therapeutics Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News Health A-Z Drugs Medical Devices Interviews White Papers More... MediKnowledge eBooks Posters Podcasts Videos Newsletters Health & Personal Care Contact Meet the Team Advertise Search Become a Member Top Health Categories Coronavirus Disease COVID-19 Diet & Nutrition Artificial Intelligence Allergies Alzheimer's & Dementia Arthritis & Rheumatology Breast Cancer Breastfeedin … herapies efficiently and reliably. Through our collaboration with RION, we will apply our expertise to support the manufacture of PEP ™ drug substance, aiming to help accelerate the availability of innovative treatments to patients worldwide.” Source: Lonza Posted in: Medical Science News Comments (0) Download PDF Copy View Supplier Profile Citations Please use one of the following formats to cite this article in your essay, paper or report: APA Lonza. (2025 … nfidential information. Read the full Terms & Conditions . Provide Feedback Submit Cancel You might also like... × Why Primary Cells Are Important for In Vitro ADME-Tox Studies
Lonza partners with Rion for cGMP manufacturing of PEP™ | Lonza posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to Li … g work in exosome-based therapies. Through our collaboration with RION, we will apply our expertise to support the manufacture of PEP™ drug substance, aiming to help accelerate the availability of innovative treatments to patients worldwide! #Lonza #RION #Innovation #CDMO Lonza 465,359 followers 9mo Edited Today, we announced a collaboration with Rion to provide cGMP manufacturing and technical support for commercial scale production of its Purified Exosome Product™ (PEP™) dr … gement of the AL Amyloidosis community as we advance toward a Biologics License Application (BLA) submission. Enrollment continues across U.S. sites, and we remain committed to advancing NXC-201 with scientific rigor and a patient-focused approach. Read the press release: https://lnkd.in/ee4PEH7P #CAR_T #Amyloidosis #CellTherapy #ClinicalTrials #Biotech #FDA #RareDiseases #IMMX 23 Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in Ligand Pharmaceuti
NL-27 Transfer Data Software Ver.1.1| RION CO.,LTD Sound Level Meters Signup Login Logout Language Japanese English Chinese Welcome Guest Login Logout Welcome Guest Technical Support Outline of Sound and Vibration Measuring Instruments RION Manga YOUTUBE Technical Documentation Product Information Sound Level Meters Vibration Meters Frequency Analyzers Sound source visualization system Seismometers Microphones and Accelerometers Anechoic Box, Anechoic Room Noise/ vibration monitoring Solution Custom-made products from RION Software Others Download Catalog Instruction Manuals Software Service S … CH CASE, YOU MAY NOT DOWNLOAD OR OTHERWISE ACCESS OR USE THIS RION SOFTWARE. 1. Grant of License Subject to the terms and conditions of this Agreement, Rion hereby grants you a limited, non-exclusive, non-transferable license to download, install, execute, and use one copy of the Rion Software on a single computing device. You are prohibited from copying, altering, reproducing, converting, and/or otherwise amending the Rion Software for any reason whatsoever, without Rion’s p … to use the Rion Software as provided in this Agreement. This Agreement does not grant you any rights to source code or to patents, copyrights, trade secrets, trademarks, or any other rights with respect to the Rion Software. Rion reserves all rights in the Rion Software not expressly granted to you in this Agreement. 3. Proprietary Information. You acknowledge that, in addition to material and elements that are protected by copyright law, the Rion Software embodies or contain … Software. 7. Export Restrictions. Japanese export laws, rules, and regulations apply to the Rion Software because it was developed in Japan. The Rion Software may not be exported, accessed, downloaded, or redistributed in any form in or to any country prohibited by Japanese export laws, rules, or regulations, or to residents or nationals of any such countries. You agree that you will comply with all applicable national and international laws that apply to the Rion Software, … es The Rion Software is not intended or designed for use in connection with any application requiring fail-safe performance, including but not limited to the operation of nuclear power facilities, air traffic control or navigation systems, weapons control systems, life support systems, or any other system whose failure could lead to injury, death
RION Appoints John Ballantyne to Chair of the Rion Scientific Advisory Board and Andrew D. Badley to Chair of the Rion Medical Advisory Board | FirstWord PHARMA You need to enable JavaScript to run this app. Loading...
RION doses first subject in Phase IIa diabetic foot ulcer therapy trial Skip to site menu Skip to page content Switch language: .translate --> CT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Approvals Operations Outsourced Services Supply Chain Data Management Medical Devices Themes Artificial Intelligence Cloud Corporate Governance Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insights Deals Jobs Filings Patents Social Media Companies Company A-Z Company Categories Prod … Chain Data Management Medical Devices Latest Ollin Biosciences secures $330m to fund Phase III OLN324 trials Viking Therapeutics commences Phase I trial of VK3019 Ascletis receives FDA clearance for Phase I trial of obesity treatment Themes Sections Artificial Intelligence Cloud Corporate Governance Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Foreign Direct Investment Latest How wearables can unlock their full potentia … hase IIa trial could lead to a pivotal study and eventually a biologics licence application for the product to treat DFUs. RION co-founder Dr Atta Behfar said: “Dosing the first subject in the Phase II trial represents a key clinical advancement of our lead programme and is an important moment for both the company and the field of exosome science. “With the Phase II effort, Rion has established key advances in exosome manufacturing and scaling, while cementing its commitment
doc/gsa · 4.5.7 · Normann Rion / dynare · GitLab Loading
Gate Valve cast rion GSA NW125 Online ordering at NexaParts. done Personal and expert advice done 25 years of experience done Fast delivery times done Competitive prices done Business ordering? Check out the benefits. menu star star star star star 8,9 based on 1.822 reviews search English Nederlands Deutsch Français person Log in support_agent Contact shopping_cart 0 Shopping cart search Nederlands Deutsch Français close Hoses keyboard_arrow_down keyboard_arrow_left Back Hoses All Hoses Suction and Discharge Hoses Hoses with Couplings Chemical Hoses Protection Hoses Maritime Hoses Stainless St … sturb_on Cons Add Message No files selected --> Photo (Not required) (jpg,png). Submit review WRITE REVIEW expand_more HIDE REVIEW expand_less News Curious about our blog? View all our posts here! Go to blogs All Press Fittings! Click here Don't miss any discount! Subscribe Need advice? Contact us: Tel: +31 38 2024 038 Email: [email protected] Or WhatsApp us NEXAPARTS BV Duurzaamheidstraat 33 8094 SC Hattemerbroek (Zwolle) the Netherlands [email protected] +31 38 202403
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Facebook Explore the things you love . Log into Facebook Email or mobile number Password Log in Forgot password? Create new account English (US) فارسی العربية Türkçe Deutsch Français (France) Polski More languages… Sign Up Log In Messenger Facebook Lite Video Meta Pay Meta Store Meta Quest Ray-Ban Meta Meta AI Instagram Threads Privacy Policy Privacy Center About Create ad Create Page Developers Careers Cookies Ad choices Terms Help Contact Uploading & Non-Users Meta © 2026
Rion to Present at the 42nd Annual J.P. Morgan Healthcare Conference | Chris Paradise, PhD LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to Linked
RION engages Lonza to scale manufacturing exosome based therapeutics Home Categories Ingredients Analysis Manufacturing Finance Company News Regulatory Drug Delivery Research & Development Sustainability Pharma 5.0 Events Directory Search Close search Subscribe Login Password Password Remember me Forgot password? Close login form Manufacturing Chemist Home Manufacturing RION engages Lonza to scale manufacturing exosome based therapeutics RION engages Lonza to scale manufacturing exosome based therapeutics Published: 30-Sep-2025 Featured companies: Lonza Manufacturing Collaboration leverage … herapies efficiently and reliably. Through our collaboration with RION, we will apply our expertise to support the manufacture of PEP™ drug substance, aiming to help accelerate the availability of innovative treatments to patients worldwide.” Share on LinkedIn Share on Facebook Featured companies Lonza As a dedicated CDMO serving the healthcare industry, we bring life-enhancing and life-saving treatments to market for our customers and their patients. We are a pioneer and...
RION Engages Lonza to Scale Manufacturing Exosome Based Therapeutics - SCbio Skip to content Download the 2026 Economic Impact Report About About SCbio Team SCbio Board of Directors SCbio Office Locations Events Calendar Events at a Glance Life + Science Annual Conference BIO International Convention 2026 Drive Demo Day 2026 Sponsorships Membership Membership Benefits Member Login Complimentary Meeting Space Meet Our Members Students Programs Drive Accelerator Available Lab Space Workforce Development Economic Development Advocacy Entrepreneurship News Industry News Share Your Company News 202 … herapies efficiently and reliably. Through our collaboration with RION, we will apply our expertise to support the manufacture of PEP ™ drug substance, aiming to help accelerate the availability of innovative treatments to patients worldwide.” Additional Information To learn more about Lonza’s Exosomes offerings, visit Lonza | Exosomes About RION RION is a clinical-stage regenerative medicine company founded out of the Mayo Clinic after two decades of exosome rese
RION Partners with Lonza for cGMP Manufacturing of Exosome Drug Substance - PharmaSource Toggle Side Panel News + Resources Downloads & Resources CDMO News CRO News Market Trends and Category Guides Biotech Profiles Podcast Directory Events CDMO Live ExM Leaders More options Sign in Sign up Search for: News + Resources Manufacturing News Podcast Downloads & Resources Biotech Profiles Directory Events Search for: Close search AI + Digital Maturity in Contract Manufacturing Exclusive Report External Manufacturing Leaders Boston Register CDMO Live Americas 2026 Early Bird Agenda Download … egenerative properties. It can be administered through several routes, allowing application across a wide range of clinical areas. “This collaboration with Lonza ensures that our proprietary exosome manufacturing platform can be scaled to meet clinical and future commercial demand,”. Atta Behfar, Cofounder and CEO of RION September 23, 2025 Lonza CDMO COMPANY PROFILE Lonza SPOTLIGHT Avoiding the Pitfalls: Five Lessons for Cell Therapy Manufacturing Success RESOURCES Resilienc
%PDF-1.5 %���� 1740 0 obj > endobj 1759 0 obj >/Filter/FlateDecode/ID[ ]/Index[1740 28]/Info 1739 0 R/Length 93/Prev 164022/Root 1741 0 R/Size 1768/Type/XRef/W[1 3 1]>>stream h�bbd```b``�� �A$S4X� ̶�R` 0 �9`O0�L d��A$� ���������k� L� l`[���� �u~; 6 endstream endobj startxref 0 %%EOF 1767 0 obj >stream h�b```�e ,@2�A��b�@��*p��qa�K¤� �"�400�p�0r��&��������V�Ѷl�tb��.~(q�A)�� ��&U�u͇W��a��\��& fb� K��� � H�PG!��x�U̙�E�1�`4e�g�`Te�axd30�F��\�h�e`/���@Z��I�bP?�hC��cU %WU endstream endobj 1741 0 obj >/Metadata 47 0 R/Outlines 51 0 R/Page … :cf467044-282f-47fd-9b89-1818c6b77715 uuid:86799d2d-69cb-448f-bce9-7e52c999321f application/pdf Dean Adobe PDF Library 11.0 endstream endobj 48 0 obj >stream h�2476S0P0476W0��@��L��F�9�4�D��T�;3�8��@!�Ȉ��,H�HLO-�����+71�(��`�L�Ct$��̇8 �i��,!fA 3��fh u��(1�(1�(1�(1"�J��@� endstream endobj 49 0 obj >stream h�l�� �P��W���(g��B��*�Wu"����o� �U����G�jE�V����NxL҃>� C�q�n)_�&B��UxW�i� w��&DpQ�㫓{����q���iL�����ʇ���� �%&e�`��2� endstream endobj 50 0 obj >/Fi
%PDF-1.6 %���� 122 0 obj > endobj 139 0 obj >/Encrypt 123 0 R/Filter/FlateDecode/ID[ ]/Index[122 27]/Info 121 0 R/Length 81/Prev 60919/Root 124 0 R/Size 149/Type/XRef/W[1 2 1]>>stream h�bbd``b`�$���Va $X��$2A,{�D� �? � $ab��$Aڔ�DHG� �H #�?c�O�A 3 endstream endobj startxref 0 %%EOF 148 0 obj >stream J���h5ˮ�$��g�Qt��O�x?;wjq|�ʮO6���� (�YV[q��3Ѽh���y��7A0Iu�$z�\w�o�� E�� >>>/Filter/Standard/Length 128/O(�#������O��FH�Nl > endobj 124 0 obj >/Metadata 13 0 R/PageLayout/OneColumn/Pages 120 0 R/StructTreeRoot 17 0 R/Type/Catalog>> endobj 125 0 obj >/Font >>>/Rotate 0/Struc
%PDF-1.7 %���� 1 0 obj >/Metadata 2035 0 R/ViewerPreferences 2036 0 R>> endobj 2 0 obj > endobj 3 0 obj > endobj 4 0 obj >/Font >/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 1224 792] /Contents 5 0 R/Group >/Tabs/S/StructParents 0>> endobj 5 0 obj > stream x��]�N I}G� �Fr��%�F2��eƻ �v V��ƍa��l��|�f䥩��ꤣ��Z k��É�Su"�������� ��;|�s���Ss��a�� f�^7J��6�Y�v�і�J7�����?4W�;�_}���ݝ�5J4��07�p��8�7L�Z�Qg?������Px��yӵ�� ���l+���h^�;l��ı�3\ 2�>8q�w��߷�lN�ܰ�s�sѷ fP���KG���t f�y���Ͻ��gbo_&�j�f�w_�՜���yyR�� ����8�������n �e����c9�?5�� Wh�G�m]��1�={����E� t�P�z|��]R��[1���I
Recruitment | Yamaha Motor Co., Ltd. Skip to Main Contents Mobility Service Business Home News Japanese Site Select Region Top News Release About Us About Us Subsidiaries Close Business & Service Mobility Asset Management Last Mile Delivery Close Join Us Internship Recruitment Close Contact Us Contact --> Home News Japanese Site Recruitment Employee Interview Haji Rehani Omary CourieMate Tanzania General Administrator Manager Rion Tosaka New Business Development Center, Mobility Service Business Division, Business Strategy Group Recruitment Background The Yamaha Motor MSB Division is committed … ional candidates, N2 level of Japanese language proficiency test is required to apply for the positions. New mobility business development in developing markets Click here for details You will be involved in planning and developing strategies in the mobility services field. In addition, you will take charge of business demonstrations, negotiating partnerships with external companies, and driving the creation and implementation of new ventures. Click here for details Product M
Business Matchmaker Welcome to the City of Gainesville --> opens in new tab or window Skip to main content Quick Links Contact Us Facebook English Select this as your preferred language Select a language to translate to English Select this as your preferred language Menu Search Services Community Government Business Employment Grants Home / Business Matchmaker Business Matchmaker Next date: Friday, July 31, 2026 | 10:00 AM to 02:00 PM Calling all business professionals in Gainesville and beyond! This networking event is designed to connect you with valuable resources, prime contractors, f
Monex Acquisition of Tempus Consulting | BGL Skip to Content Search for: Search Worldwide Careers Contact Us Search for: Search Services Mergers & Acquisitions Capital Markets Advisory Financial Sponsors Financial Restructuring Valuations & Opinions Other Advisory Services Services Overview Sector Coverage Consumer Healthcare & Life Sciences Industrials Infrastructure Services Technology Real Estate Sectors Overview Transactions View Additional Transactions Research & Insights View All Research View Insights Articles About Us Our Firm Global Capabilities Our Team Our Founde
Rion-Antirion Bridge, Greece | TITAN Enter your email Address --> Newsroom News and Media Releases Media library Annual reports Careers 10 Reasons to work with us Internships Career opportunities TITAN WORLDWIDE Albania Bulgaria Brazil Egypt Greece Kosovo N. Macedonia Serbia TÜRKIYE USA About Us About Us TITAN is a leading international business in the building and infrastructure materials industry, committed to providing innovative materials, solutions, and services needed for safe and sustainable homes, buildings, and infrastructure. Our Strategy Our Purpose and Values Corporate Governance B … E CAPITAL SECURITIES TRANSFER FROM THE DEPOSIT SHARE OF LOAN & CONSIGNMENT FUND REGULATORY/STOCK EXCHANGE ANNOUNCEMENTS IR CONTACT Sustainability Sustainability Sustainability is an integral part of our business. We seek to make a positive difference to people, society and the environment, through our products and operations, and we collaborate with our stakeholders to address local and global challenges. Our Focus Creating Value for All Stakeholder Engagement Material I … E CAPITAL SECURITIES TRANSFER FROM THE DEPOSIT SHARE OF LOAN & CONSIGNMENT FUND REGULATORY/STOCK EXCHANGE ANNOUNCEMENTS IR CONTACT Sustainability .click"> Our Focus Creating Value for All Stakeholder Engagement Material Issues ESG Targets 2025 Supply Chain Management Global Collaborations & Commitments Sustainability Governance Environment Environmental Management Circular Economy Health and Safety People and Community Sustainability in Action Annual Reports ESG Rat
New Sponsorship Alert‼️... - Hattiesburg Public Schools Facebook Log In Hattiesburg Public Schools's Post Hattiesburg Public Schools June 15 at 10:33 AM · Shared with Public New Sponsorship Alert We’re excited to welcome Coca-Cola Bottling Company - Hattiesburg, an official sponsor of the 2026 Men Matters Conference! Thank you, Coca-Cola, for joining us in supporting, uplifting, and empowering men in our community. Your partnership helps make this event possible! Hattiesburg, don't miss this incredible event!! DON'T MISS OUT THIS SATURDAY, MEN! REGISTER TODAY: https://forms.gle/
BERNARD RION Log in Book your stand EN FR Discover Destination Paris About the show Sustainability Partners Exhibit Why exhibit Increase your visibility 2026 exhibitor area Optimise your experience Visit Why visit Exhibitor catalogue Products catalogue Preparation is key Nouvelle Vague Unsigned Club programme Media kiosk Academy Programme overview Detailed programme Media Practical information Opening hours, access & map Bars & restaurants Be Spirits The Other Sip Show more Loading... Opening Hours Monday 15 February: 9am–7.00pm Tuesday 16 February: 9am–7.00pm Wednesday 17 February: 9a
%PDF-1.5 %���� 95 0 obj > endobj 109 0 obj >/Encrypt 96 0 R/Filter/FlateDecode/ID[ ]/Index[95 24]/Info 94 0 R/Length 74/Prev 5144205/Root 97 0 R/Size 119/Type/XRef/W[1 2 1]>>stream h�bbd``b`� $;��=�[� ��"n��� �Dx�;� $ �3012���H����� �/� " endstream endobj startxref 0 %%EOF 118 0 obj >stream ��^�U ��P0K�\�X-gH�D�_�q%�C/!īF�y�~m�7������1P��Y���ue��r�"h���Gս��ūʇ���Gn���}�Q����>H~@[��t�a��sT�À��>C���Z����e�b9�I endstream endobj 96 0 obj > endobj 97 0 obj > endobj 98 0 obj >/ProcSet[/PDF/Text/ImageB]/XObject >>>/Rotate 0/Type/Page>> endobj 99 0 obj >stream �[�Wn����ۺAn2�
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Publications - RION About Our Science Pipeline Publications News Careers Select Page PUBLICATIONS PUBLICATIONS Tissue Engineering Part A: Research Advances | September 2023 A Ready-to-Use Purified Exosome Product for Volumetric Muscle Loss and Functional Recovery Large skeletal muscle defects owing to trauma or following tumor extirpation can result in substantial functional impairment. Purified exosomes are now available clinically and have been used for wound healing. The objective of this study was to evaluate the regenerative capacity of commercially available exosomes on an animal model o … n in animals. The team did not detect any infection or off-target toxicity with application of PEP Read More Discovery’s Edge| October 12, 2022 Early Research Toward a Cell-Free Solution for Stress Urinary Incontinence The research team used regenerative purified exosome product, known as PEP, derived from platelets to deliver messages into the cells of preclinical models. Exosomes are extracellular vesicles that are like a delivery service moving cargo from one cell to … n in animals. The team did not detect any infection or off-target toxicity with application of PEP Read More Regenerative Medicine, Vol. 17, NO. 11 | October 4, 2022 Platelet-derived Exosomes Induce Cell Proliferation and Wound Healing in Human Endometrial Cells. Aim: To investigate the regenerative effects of a platelet-derived purified exosome product (PEP) on human endometrial cells. Materials & methods: Endometrial adenocarcinoma cells (HEC-1A), endometrial stromal ce … compatibility with hydrogel-based sustained delivery approaches. In vitro, the application of PEP to skeletal muscle satellite cells in vitro drove proliferation and differentiation in an NF-κB-dependent fashion, with full inhibition of impact on exposure to resveratrol. PEP biopotentiation of collagen-1 and fibrin glue hydrogel achieved sustained exosome release at 37 °C, creating an ultrastructural “bead on a string” pattern on scanning electron microscopy. Initial testing … compatibility with hydrogel-based sustained delivery approaches. In vitro, the application of PEP to skeletal muscle satellite cells in vitro drove proliferation and differentiation in an NF-κB-dependent fashion, with full inhibition of impact on exposure to resveratrol. PEP biopotentiation of collagen-1 and fibrin glue hydrogel achieved sustain
2025 Dan Rion Memorial Antique Engine Jamboree Exhibitor Form 2025 Dan Rion Memorial Antique Engine Jamboree Exhibitor Form Name * Email [email protected] Address, City, State, Zip Code * Phone Number * Additional Attendee(s) Equipment to be exhibited (please describe with year, make and model, if applicable) * I need a space (ft. long x ft. wide) * I need with me (check all that apply - this means you need these items nearby rather than in the event parking lot) Trailer Vehicle I will be attending: * ONLY Saturday, September 6 ONLY Sunday, September 7 Saturday, September 6 and Sunday, Septe … /presenter engages in activity on the premises of HMM. * I agree to these terms Submit Should be Empty:
Honoring Our History: A Conversation with CoreCivic's First Female Warden Sharon Johnson Rion CoreCivic has updated its Privacy Policy for California residents. X Home Search About Newsroom Corporate Responsibility Foundation Partnership Investors Facility Locator Contact Employee Access Careers Who We Are Safety Community Properties For Families Reentry MENU CLOSE Who We Are Safety Community Properties For Families Reentry Home Search About Newsroom Corporate Responsibility Foundation Partnership Investors Facility Locator Contact Employee Access Careers News Honoring Our History: A Conversat
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Rion Sports Products Co., Ltd. Las Vegas Home Brand List All Brands MAGIC PROJECT SOURCING OFFPRICE All Products Education & Experiences All Sessions Education Experiences Event Maps Interactive Map Las Vegas Overview Plan your trip Book Your Hotel Event Info Buyer's Guides Travel & Transportation Discover Las Vegas Buyer FAQs Exhibitor FAQs Contact Us *NEW* Feature Guides Show more Sign In Register Now Loading... Important Links Register to Attend MAGIC | North & Central Hall PROJECT | North Hall SOURCING | South Hall OFFPRICE | Central Hall Contact Us Show Schedule Tuesday,
RIoN - 2026 Investment Bank Profile, Deals and M&A - Tracxn JavaScript is disabled in your browser. enable it to enjoy the full features of Tracxn. Your browser was unable to load all of Tracxn resources. They may have been blocked by your firewall, proxy or browser configuration. Press Ctrl+F5 or Ctrl+Shift+R to have your browser try again and if that doesn't work, click here to retry or mail us at [email protected] Internal Server Error Toggle navigation Customers Investment Industry Venture Capital Funds Private Equity Funds Accelerators & Incubators Investment Banks Corporates and
ALRION - alrionpillarcapital.com ALRION ABOUT STRATEGIES PORTFOLIO TEAM IMPACT INSIGHTS INVESTORS CONTACT Search Alrions is an institutional-grade investment platform built on the principle of Independence by Design. We have evolved from a traditional advisory model into a unified ecosystem where four distinct investment strategies operate with absolute autonomy under one rigorous institutional framework. Know More of Alrion 2026 Global Plans The New Paradigm in Alternative Investments Our Story Investment Strategies: Independence by Design Founded in New York’s Financial District by Dr. Oluse … risk framework, yet powered by shared operational excellence. STRATEGIES Hedge Fund LP: Global Macro Excellence A systematic approach to alpha generation, combining quantitative modeling with fundamental analysis to capitalize on macroeconomic dislocations. Target Returns: 12–15% Net IRR. Strategy: Multi-timeframe cross-asset relative value. Risk Control: Daily 95% VaR monitoring; Maximum 300% gross exposure. Terms: 2.0% Mgmt / 20% Perf; $1M Minimum. MissionPrivate Equity LP … visory Board including former government and military leaders. Community Equity Fund LP: Impact Through Investment A revolutionary model proving that underserved markets represent the most compelling risk-adjusted opportunities in New York. Mandate: 51%+ Minority/Women-Owned Business Enterprises (MWBEs). Social Impact: Measurable local hiring, wealth building, and neighborhood stabilization. Structure: Seeded by carried interest from Alrions’ institutional strategies, creatin … ous cycle of capital. Institutional Governance & Transparency Every Alrions fund adheres to the highest standards of fiduciary duty: Audit & Admin: Annual audits by Big Four firms and third-party administration. Alignment: Significant GP commitments across all funds. Reporting: Monthly transparency protocols for liquid strategies; quarterly deep-dives for private markets. Institutional Access Alrions materials are intended solely for Qualified Purchasers and Accredite … Company -About -Leadership -Careers -News and Media - Contact Strategies -Hedge Fund -Private Equity - Venture Capital - Community Equity - Portfolio Resources - Insights - Research - Events - Newsletter - Press Kit Investors -Fund Info - Performance - Document Library - Investor Login - Contact IR Legal - DIsclosure - Privacy Policy - Terms of U
Sponsors | Join Our Sponsorship Community — Texas Equine Veterinary Association Skip to Content Open Menu Close Menu About Back in the Saddle Summer CE Symposium Memberships Remuda SCAAEP Job Fair Sponsors Store Texas Equine Foundation Login Account 0 0 Join the Mailing List About Back in the Saddle Summer CE Symposium Memberships Remuda SCAAEP Job Fair Sponsors Store Texas Equine Foundation Login Account 0 0 Join the Mailing List Open Menu Close Menu About Back in the Saddle Summer CE Symposium Memberships Remuda SCAAEP Job Fair Sponsors Store Texas Equine Foundation Login Account Join
Pipeline - RION About Our Science Pipeline Publications News Careers Select Page Our Pipeline Our Pipeline The Future of Medicine is Here: Revolutionizing Exosome Science to Heal from Within! At RION, we’re harnessing the power of platelet-derived exosomes, nature’s own delivery vehicles, to create the most advanced exosome clinical pipeline with PEP™ The Future of Medicine is Here: Revolutionizing Exosome Science to Heal from Within! At RION, we’re harnessing the power of platelet-derived exosomes, nature’s own delivery vehicles, to create the most advanced exosome cli
RION | About Rion : History Search function requires to enable browser's JavaScript settings. Skip Main Menu and go to the body text area in this page. Sitemap 日本語 中文 Products Products Top Audiological Equipment (Hearing Instruments/Medical Equipment) Sound and Vibration Measuring Instruments Particle Counters About Rion About Rion Top Message from President Corporate Philosophy Corporate Outline and Corporate Brand Contents of Business Financial Highlights History Location Rion's Efforts for Environmental Measures Rion's Efforts for Quality of Products SDGs and Social Contribution Distributor … introduced. 1971 Rion hearing instrument (HA-27 series) receives a Good Design Award in Japan, as first for hearing instruments. 1972 Nagoya Branch (current Tokai Office) is opened. 1974 Hiroshima Branch (closed in May 2002, merged with the current West-Japan Office) is opened. Rion sound level meter got the type approval of the Measurement Act, as first for sound level meters. 1977 Airborne Particle Counter (KC-01) is introduced. 1979 Rion Electronic Industries Co., Ltd. in
Payton Rion | Stream Realty Partners Find People Find Space Explore Services Transaction, Advisory & Management Services Landlord Representation Tenant Representation Capital Markets Investment Management Value Preservation Advisors Property Management Design & Development Development Services Construction Management Specialized Services Manufacturing, Food & Beverage, and Distribution Workplace Strategy Law Firm Practice Group Marketing, Research & Technology Services Applied Technologies Strategic Marketing Actionable Research View All Services Property Types Office Services Industrial Servi … s' timely updates on trends, people and action in the industry. Email * CAPTCHA Submit Services Property Types Actions & Insights Client Solutions Our Company Locations Careers Contact Us Tenant Portal Linkedin Twitter Facebook Instagram © 2026 Stream Realty Partners, LP Privacy Policy TREC Consumer Protection Notice TREC Information About Brokerage Services We collect cookies to analyze our website traffic and performance; we never collect any personal data. Accept
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
About - RION About Our Science Pipeline Publications News Careers Select Page Revolutionizing Exosome Science to Heal From Within Revolutionizing Exosome Science to Heal From Within Our Story Following decades of large-scale trials probing the utility of cell-based regenerative therapies, RION’s co-founders Dr. Andre Terzic and Dr. Atta Behfar discovered that the driving force behind tissue repair was exosome signaling. This pivotal discovery launched RION’s vision to redefine regenerative medicine. By leveraging their exosome research, Drs. Behfar and Terzic envisioned a new parad … Prior, Dr. Terzic was conferred: the American Heart Association Basic Research Prize “for pioneering applications of emerging technologies to advance the diagnosis and treatment of cardiovascular disorders;” the Madrid Award for Excellence in Cardiovascular Regenerative Research “for leadership and success in translating stem cell theory into practice;” and the Hellenic Heart Failure Research Society Honorary Fellowship for “contributions to Hea
Tietosuojavalintasi guce guce Tietosuojasi on meille tärkeää Tietosuojavalintojasi käytetään kaikissa Yahoo-konsernin tarjoamissa sivustoissa ja sovelluksissa. Yahoo käyttää evästekäytännöstämme ."> Evästeet Evästeiden (sekä vastaavien tekniikoiden, esimerkiksi verkkotallennuksen) avulla verkkosivustojen sovellusten ylläpitäjät voivat tallentaa ja lukea laitteesi tietoja. Lue lisää evästekäytännöstämme . evästeitä seuraaviin tarkoituksiin: tarjotaksemme sivustomme ja sovelluksemme sinulle todentaaksemme käyttäjät, estääksemme roskapostia ja väärinkäytöksiä sekä toteuttaaksemme tietoturvatoimia
News - RION About Our Science Pipeline Publications News Careers Select Page NEWS NEWS September 23, 2025 RION Engages Lonza to Scale Manufacturing Exosome Based Therapeutics Read More September 9, 2025 RION Launches INTENT Biologics to Develop Late-Stage Clinical Exosome-Based Therapies in Inflammation & Immunology; Appoints Biopharma Veteran Suneet Varma as CEO Read More May 1, 2025 RION names Biopharma Veteran Suneet Varma as Senior Advisor to Spearhead Expansion into Regenerative Therapeutics Read More March 11, 2025 RION Announces First Patient Enrolled in Phase 1b Clinical Study Eval … Healthcare Conference Read More November 11, 2024 RION Awarded the Entrepreneur Award at the 11th Annual R.A.V.E Read More September 25, 2024 RION Expands Leadership Team with the Appointment of Five Renowned Experts to Advisory Boards Read More September 10, 2024 RION Announces Initiation of Phase 1b Clinical Study to Evaluate Purified Exosome Product™ (PEP™) for Knee Osteoarthritis Read More May 7, 2024 RION Announces First Patient Dosed in Phase 2 Clinical Study of Purifie … al Research Institute for Chemical Defense Recieved $2.4M Department of Defense Award to Advance Exosome-Based Research in Pulmonary Therapeutics Read More January 25, 2023 RION Announces the Advisory Appointments of John Ballantyne, Ph.D., to Chair of the Rion Scientific Advisory Board and Andrew D. Badley, M.D., to Chair of the Rion Medical Advisory Board Read More For general information, please email [email protected] For partnering inquiries, please email [email protected]
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
%PDF-1.6 %���� 1796 0 obj >stream h�tR�k�0�W��F���,C 8u��6�3 -��&jj���R����${�PB���{�;�4]��t �k8?gu��]��+�6O���gV�)q�m�]��)\Ջ���@ �g3��H�,�eٽ� A�(�?��ïٌ�����!x6_��~�����Ք�]-A���8�x�,]�M�γ��ѳ˿�[]�l벮?��|��� >stream h�L�A �0����t��7�f!B8� �CG/�}� 6��п/����>����m �wJGJ�!CQb)QH��b�y���O�Cz4~"89E��:h[x�i�g�_o#c���ۉ\HĬ�qC��1��Tg; � �-2~ zY��N�Wj��L�1e endstream endobj 1798 0 obj >stream h�26R0P���w�/�+Q024���L)�66 )���i #30mhba0��P�D��T��$������� endstream endobj 1799 0 obj >stream h�26V0P06Q�4T���w�/�+r��3S���� A FF�� B[��icc3mn �c��RA����C* R�B��vvp�-�&[�u … dc780d10db xmp.id:46c60a5c-6137-4031-b7c5-1d4672b724a8 proof:pdf converted from application/x-indesign to application/pdf Adobe InDesign CC 2015 (Macintosh) / 2016-06-30T13:39:31-04:00 xmp.iid:c4eae88c-8997-4c23-8b87-bbdc780d10db xmp.did:c4eae88c-8997-4c23-8b87-bbdc780d10db xmp.did:c4eae88c-8997-4c23-8b87-bbdc780d10db default application/pdf Adobe PDF Library 15.0 False endstream endobj 37 0 obj >>> endobj 40 0 obj >stream H����N�0E���Y& � {�Ƕ �)�Re���L���-� � >stream H� … ���1�G����x�#����-����w endstream endobj 79 0 obj > endobj 80 0 obj >stream application/postscript Print HD - Adsmith 2016-06-20T09:27:01-04:00 2016-06-20T09:27:01-04:00 2016-06-20T09:27:01-04:00 Adobe Illustrator CC 2015 (Macintosh) xmp.iid:c1a689a8-55da-43f2-8409-22fa6196e195 xmp.did:c1a689a8-55da-43f2-8409-22fa6196e195 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf xmp.iid:cc9deec7-9fb7-4db1-a137-3387ff12d005 xmp.did:cc9deec7-9fb7-4db1-a137-3387ff12d005 uuid:5D2089249 … 016-04-08T15:56:02-04:00 Adobe Illustrator CC 2015 (Macintosh) / converted from application/postscript to application/vnd.adobe.illustrator converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:c1a689a8-55da-43f2-8409-22fa6196e195 2016-06-20T09:27:01-04:00 Adobe Illustrator CC 2015 (Macintosh) / converted from application/postscript to application/vnd.adobe.illustrator Print False False 1 8.500000 11.000000 Inches Black PANTONE 200 C PANTONE … ��MV���T����|��� e��a�[�/�л2>r,�P��c-楚��R� WN����4����F��h��C�ɞ�xh�yo�נ ( �8~RFp �7l!rwNb��^������tW��de���)��LcYV �@�N`� .��� R� � �� ���jb�I�g�`u�����p� \3a�z #��` ��Rl1[���D&��]5 G�Ht^�\�G+�� W(�PS Z�"Fh)�[��9 D�u�׳O Ô;N��۷�Q�:��� 4ğ�TģRL] ꯱�P�$��=;����y̯�a�Ĩ��γ7� o����;#��Z� ��$�D���E� ��c�/TBϐ���b| ����
RION Vet Launches with First-in-Class Biologic for Animal Health | Rion Vet posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you … rs 906 followers 8mo Edited Report this post We’re pleased to announce that our Grant Awarding Committee has completed its 2025 Clinical Research Project funding round. Following careful review, funding of nearly £110,000 was awarded to eight projects including four jointly funded with BSAVA affiliate groups. The successful projects include: 👁️ Identifying genetic risk factors for primary closed angle glaucoma in the Welsh Springer Spaniel at the University of Cambridge Vet … rt the future of small animal veterinary medicine in these specialist areas. To fund out more about these grants and other projects we’ve supported in 2025, visit https://lnkd.in/e8hxP8nt 15 Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in NewsRamp™ 3,281 followers 8mo Edited Report this post PetVivo Holdings Inc will present at the Spartan Capital Securities, LLC Second Annual Investor Conference, highlighting its groundbreaking veterinary medica
Home - RION About Our Science Pipeline Publications News Careers Select Page Revolutionizing exosome science to heal from within Learn More Revolutionizing exosome science to heal from within Learn More “For decades, the promise of cell-based therapies remained just that – a promise. At RION, we are turning that promise into reality by leveraging the remarkable properties of exosomes. This is more than just innovation; it’s a revolution in regenerative medicine.” – Dr. Atta Behfar, Co-founder, RION “For decades, the promise of cell-based therapies remained j … y. This breakthrough not only amplifies the potential for extensive therapeutic application but also represents a substantial advance in the commercial viability of exosome-based treatments. PEP™ is RION’s innovative Drug Substance containing trillions of platelet-derived regenerative exosomes. Innovation SCALING EXOSOME INNOVATION: Our Breakthrough Manufacturing Process Produces PEP™ (Purified Exosome Product™) RION has developed a proprietary process that isolates reg … y. This breakthrough not only amplifies the potential for extensive therapeutic application but also represents a substantial advance in the commercial viability of exosome-based treatments. PEP™ is RION’s innovative Drug Substance containing trillions of platelet-derived regenerative exosomes. Innovation Regenerative Exosomes in a Bottle Learn More Purified Exosome Product™ (PEP™) The result of RION’s proprietary manufacturing process is a novel ingredient called Purif … el ingredient called Purified Exosome Product (PEP™). Depending on the clinical application each vial of PEP™ can be manufactured to contain up to 2 trillion regenerative exosomes. PEP™ is packaged as a lyophilized powder that is stored at room temperature with 24 months of shelf life. Thus, PEP™ can be easily reconstituted in water or saline to deliver the regenerative potential of exosomes to tissues in the body. Properties of PEP™ RION’s research shows that PEP™ has the ab … el ingredient called Purified Exosome Product (PEP™). Depending on the clinical application each vial of PEP™ can be manufactured to contain up to 2 trillion regenerative exosomes. PEP™ is packaged as a lyophilized powder that is stored at room temperature with 24 months of shelf life. Thus, PEP™ can be easily reconstituted in water or saline to
Sponsors & Exhibitors — Hair Health Summit 0 Skip to Content Hair Health Summit Registration Home Agenda Faculty Venue Sponsors & Exhibitors Accreditation Exhibit & Sponsorship Opportunities Resident Travel Award HHS 2025 Gallery Register Here Open Menu Close Menu Hair Health Summit Registration Home Agenda Faculty Venue Sponsors & Exhibitors Accreditation Exhibit & Sponsorship Opportunities Resident Travel Award HHS 2025 Gallery Register Here Open Menu Close Menu Registration Home Agenda Faculty Venue Sponsors & Exhibitors Accreditation Exhibit & Sponsorship … xhibitors Accreditation Exhibit & Sponsorship Opportunities Resident Travel Award HHS 2025 Gallery Register Here Thank you to our Sponsors and Exhibitors! Ally Sponsor Diamond Sponsor Platinum Sponsors Abbvie Arcutis Gold Sponsor also sponsoring 2 breaks Chemistry RX KenVue/Neutrogena CeraVe also Non CME talk sponsor Bronze Sponsors Nutrafol Canfield Scientific, Inc. Lilly National Alopecia Areata Foundation Silver Sponsor also Non CME talk sponsor Pfizer Rion Aesthetics
Dr Atta Behfar on Exosome-Based Therapeutics at Rion | Max Brennan, MSc posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agr … iable Therapeutics” Save the date: 09 May 2026 Visit our website to register or apply to showcase your startup (limited slots available): https://lnkd.in/e2XNJgp5 #OxBio26 #OxBioSummit #Biotech #Innovation #TranslationalScience #Oxford #Startups Imperial Entrepreneurs Oxford Artificial Intelligence Society OX1 Incubator Oxford Founders Society Oxford Venture Capital Network University of Oxford Oxbridge AI Challenge & Oxbridge AI X 4 Like Comment Share Copy LinkedIn Faceb
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Rion to Present at the 42nd Annual J.P. Morgan Healthcare Conference - Medical Alley Home About Services Initiatives News Events Join us Partner Directory Academy Job board Academy Log In My Account Search Partner Directory Academy Job Board Academy Log In Cart My Account Search About Services Initiatives News Events Join Us Home About Services Initiatives News Events Join us Partner Directory Academy Job board Academy Log In My Account Search Fewer Handoffs, Faster Innovation: Why Vertical Integration Matters More Than Ever News ROCHESTER, Minn.–( BUSINESS WIRE )–Rion, a leader in
Episode 150 - Dr Atta Behfar -… - The BioHub - by Avetix - Apple Podcasts Search Home New Top Charts Search April 16 30 min Episode 150 - Dr Atta Behfar - Founder of Rion The BioHub - by Avetix Play In this episode of The BioHub Podcast , Max sits down with Dr. Atta Behfar, Co-Founder of Rion and Professor of Regenerative Medicine at Mayo Clinic. Atta’s work at Mayo led to a key discovery that became the foundation for Rion, a clinical-stage company developing exosome-based therapeutics through its Purified Exosome Product (PEP) platform. In this conversation, Atta shares the story behind that
Episode 150 - Dr Atta Behfar - Founder of Rion - The BioHub - by Avetix | Podcast on Spotify
Episode_64 - Aesthetic Record EMR Skip to content Features Payments & Revenue Appointment Booking Client Engagement Clinical Solutions Practice Management Chart-to-Cart AR Pay eGift Cards Text2Pay Patient Financing Patient Wallet Pricing Variations AR Capital Featured Revitalize Your Skin at Our Spa Indulge in expert skincare treatments that restore your natural glow. From facials to personalized plans, experience relaxation and rejuvenation today! Online Booking & eCommerce Smart Scheduling Cancellation Policy & Service Deposits Waitlist Management Featured Your Skin, Your Glow In … regeneration (eventually the heart), and as a byproduct, he found an invaluable application within aesthetics. Looking into the future, he discusses what is possible with injectable exosomes to supercharge what filler, toxin and biostimulators can do in the tissue. We won’t need to just fill or relax wrinkles, but there is the potential to repair the tissue enough that it’s no longer a concern. If Dr. Behfar is where it started, Dr. Wyles is how it’s going. Not only is she an … on the research front and get a solid breakdown of the science and the clinical application of something as novel as platelet-derived exosomes. In addition, Dr Wyles provides a checklist of sorts for you to consider before bringing exosomes into your practice. It’s important to check things like donor quality, batch consistency, batch effectiveness, platelet or stem-cell derived, and to ask for the clinical research that is backing the product. We know Rion Aesthetics has no
Lonza Group - Today, we announced a collaboration with... Facebook Log In Lonza Group's Post Lonza Group Verified account September 23, 2025 · Shared with Public Today, we announced a collaboration with RION to provide cGMP manufacturing and technical support for commercial scale production of its Purified Exosome Product™ (PEP™) drug substance for late phase clinical supply and beyond. PEP™ is an exosome-based therapeutic platform candidate with immunomodulatory, anti-inflammatory and tissue regenerative properties. Stabilized regenerative exosomes promote tissue repair and can be admini
414 Capital acquires RIóN, a key player in Mexican M&A scene - Leaders League Rankings News & Trends Special reports Events Research Guidebooks 414 Capital acquires RIóN, a key player in Mexican M&A scene Posted on May 7, 2024 Link copied ! 414 Capital, a leading corporate finance advisory platform with operations in the Americas, has acquired RIóN, one of the key players in the middle-market M&A sector in Mexico. As a result of the transaction, 10 seasoned professionals will be joining 414 Capital in the Mexico City, Monterrey and Madrid offices. Established in 1990, RIóN is an ad
Careers - RION About Our Science Pipeline Publications News Careers Select Page Careers Come work with RION in the heart of downtown Rochester, a vibrant rapidly-growing city located in Southeast Minnesota. Located in the home of the number one hospital in the country, time and again, Rochester, MN, ranks among the best places to live in the United States owing to its affordable cost of living, healthy lifestyle, stellar school systems, and exceptional quality of life. Rochester is also well known as a global destination for health and wellness. For the past decade, state officials in c … our current openings. If one of the available roles is right for you, click the Apply Now and be redirected to the posting. Available Positions Senior Scientist, Quality Control About Rion Rion is a clinical-stage biotechnology company based in Rochester, Minnesota, founded through the Mayo Clinic Employee Entrepreneurial Program. Our mission is to develop clinically impactful and accessible therapies using innovative regenerative medicine technologies based on extracellular … the United States. Visa sponsorship is not available for this position. How to Apply : Please submit a resume (and optional cover letter). Include a brief summary of relevant analytical methods experience and availability to start. Rion recognizes the importance of balance and flexibility in our work environment. We offer competitive benefits, services, and programs that provide employees with resources to pursue their career goals—both at work and in their personal lives. W … ffairs Position Description The Sr. Manager Regulatory Affairs will prepare and submit regulatory agency applications, reports, or correspondence with minimal oversight and will report to the Sr. Director of Regulatory Affairs at Rion. Qualifications: One of the following combinations of education and experience is required: (A) a minimum of a bachelor’s degree plus 10 years of health regulated industry experience OR (B) a master level degree plus 8 years of health regulated … ole for future consideration. We’ll reach out when we have something that fits! Submit Resume Our Perks Health Insurance Dental Insurance Vision Insurance Flexible Spending Accounts (FSA) 401K or IRA Retirement Savings Supplemental Life Insurance Short and Long-Term Disability Insurance Paid Family Leave Paid Time Off Paid Holidays Parking Benefi
Careers - RION About Our Science Pipeline Publications News Careers Select Page Careers Come work with RION in the heart of downtown Rochester, a vibrant rapidly-growing city located in Southeast Minnesota. Located in the home of the number one hospital in the country, time and again, Rochester, MN, ranks among the best places to live in the United States owing to its affordable cost of living, healthy lifestyle, stellar school systems, and exceptional quality of life. Rochester is also well known as a global destination for health and wellness. For the past decade, state officials in c … our current openings. If one of the available roles is right for you, click the Apply Now and be redirected to the posting. Available Positions Senior Scientist, Quality Control About Rion Rion is a clinical-stage biotechnology company based in Rochester, Minnesota, founded through the Mayo Clinic Employee Entrepreneurial Program. Our mission is to develop clinically impactful and accessible therapies using innovative regenerative medicine technologies based on extracellular … the United States. Visa sponsorship is not available for this position. How to Apply : Please submit a resume (and optional cover letter). Include a brief summary of relevant analytical methods experience and availability to start. Rion recognizes the importance of balance and flexibility in our work environment. We offer competitive benefits, services, and programs that provide employees with resources to pursue their career goals—both at work and in their personal lives. W … ffairs Position Description The Sr. Manager Regulatory Affairs will prepare and submit regulatory agency applications, reports, or correspondence with minimal oversight and will report to the Sr. Director of Regulatory Affairs at Rion. Qualifications: One of the following combinations of education and experience is required: (A) a minimum of a bachelor’s degree plus 10 years of health regulated industry experience OR (B) a master level degree plus 8 years of health regulated … ole for future consideration. We’ll reach out when we have something that fits! Submit Resume Our Perks Health Insurance Dental Insurance Vision Insurance Flexible Spending Accounts (FSA) 401K or IRA Retirement Savings Supplemental Life Insurance Short and Long-Term Disability Insurance Paid Family Leave Paid Time Off Paid Holidays Parking Benefi
Rion Aesthetics to present at IMCAS, and showcase the innovative, breakthrough, and highly effective nature of platelet-derived extract — Rion Aesthetics 0 Skip to Content About Us Our Products News & Events Contact Us Become a Provider Open Menu Close Menu About Us Our Products News & Events Contact Us Become a Provider Open Menu Close Menu About Us Our Products News & Events Contact Us Become a Provider Rion Aesthetics to present at IMCAS, and showcase the innovative, breakthrough, and highly effective nature of platelet-derived extract Jan 26 Written By Winston Studio “At
RION Announces Initiation of Phase 2A Clinical Study for Purified Exosome Product™ (PEP™) in Diabetic Foot Ulcers - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Tr … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search News Drug Development RION Announces Initiation of Phase 2A Clinical Study for Purified Exosome Product™ (PEP™) in Diabetic Foot Ulcers January 30, 2024 | 6 min read Twitter LinkedIn Facebook Email Print RION’s Phase 2A clinical trial focuses on evaluating the safety and efficacy of Platelet Exosome Produc … e the way for a pivotal study followed by the submission of a Biologics License Application (BLA). PEP™ addresses a significant unmet medical need in the realm of diabetic wound care. Dr. Atta Behfar, Co-founder of RION, said, “The progress we've made in advancing PEP™, reflects our deep commitment to developing powerful exosome therapies that unleash the body’s ability to heal from within. Not only will this study address a critical unmet need in chronic wound care, but it’s … mination. We seek to break the cycle of pain, loss, and economic burden through application of our next-generation regenerative exosome technology. We will remain undeterred in our pursuit to have PEP™ become the first biologic to be approved for the treatment of DFU in over 25 years. References 1. Armstrong DG, Tan TW, Boulton AJM, Bus SA. Diabetic Foot Ulcers: A Review. JAMA. 2023 Jul 3;330(1):62-75. doi: 10.1001/jama.2023.10578. PMID: 37395769; PMCID: PMC10723802. 2 … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
RION Announces the Advisory Appointments of John Ballantyne, Ph.D., to Chair of the Rion Scientific Advisory Board and Andrew D. Badley, M.D., to Chair of the Rion Medical Advisory Board - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search News Business RION Announces the Advisory Appointments of John Ballantyne, Ph.D., to Chair of the Rion Scientific Advisory Board and Andrew D. Badley, M.D., to Chair of the Rion Medical Advisory Board January 25, 2023 | 4 min read Twitter LinkedIn Facebook Email Print RION, a clinical-stage regenerative me … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
RION Announces Final Patient Enrolled in the Phase 2 Clinical Study for Purified Exosome Product™ (PEP™) in Diabetic Foot Ulcers - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases RION Announces Final Patient Enrolled in the Phase 2 Clinical Study for Purified Exosome Product™ (PEP™) in Diabetic Foot Ulcers January 13, 2025 | 5 min read Twitter LinkedIn Facebook Email Print ROCHESTER, Minn.--(BUSINESS WIRE)--RION, a clinical-stage regenerative medicine company at the forefront of e … o initiate a pivotal Phase 3 study, with the goal of filing a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA). About RION RION was born out of Mayo Clinic after two decades of research and innovation. RION is located in Rochester, MN and is internationally recognized for its pioneering advancements in isolating and mass-producing platelet-derived regenerative exosomes into shelf stable PEP™. RION is rewriting the regenerative medicine play … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
RION, Mayo Clinic, and the U.S. Army Medical Research Institute for Chemical Defense Receive $2.4M Department of Defense Award to Advance Exosome-Based Research in Pulmonary Therapeutics - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search BioMidwest RION, Mayo Clinic, and the U.S. Army Medical Research Institute for Chemical Defense Receive $2.4M Department of Defense Award to Advance Exosome-Based Research in Pulmonary Therapeutics November 20, 2023 | 3 min read Twitter LinkedIn Facebook Email Print RION, a leading clinical-stage regenerative medicine c … ic and the U.S. Army Medical Research Institute for Chemical Defense on a $2.4M grant awarded from the Department of Defense. Research aims to employ RION's exosome technology platform to better understand regenerative medicine in war zones for pulmonary disease caused by smoke inhalation. Exosomes are predicted to significantly transform healthcare across a variety of areas in the coming years, with RION leading this groundbreaking innovation. Active human investigational tr … the U.S. Army Medical Research Institute for Chemical Defense (ICD) on a $2.4M grant awarded from the Department of Defense. This grant accelerates a critical research initiative aimed at exploring the therapeutic potential of RION's proprietary Purified Exosome Product™ (PEP™) for the treatment of Chronic Obstructive Pulmonary Disease (COPD) and other challenging pulmonary conditions, which can impact soldiers and veterans exposed to airborne hazards in war zones. This pres … initiative is committed to addressing this critical healthcare challenge. “This grant speaks to the potential of our purified exosome product to deliver on the promise of regenerative medicine – leveraging the body’s innate ability to heal,” said Dr. Atta Behfar, CEO and Co-Founder of RION. “We look forward to unlocking the therapeutic possibilit
RION Announces First Patient Enrolled in Phase 1b Clinical Study Evaluating Purified Exosome Product™ (PEP™) for Knee Osteoarthritis - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing De … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases RION Announces First Patient Enrolled in Phase 1b Clinical Study Evaluating Purified Exosome Product™ (PEP™) for Knee Osteoarthritis March 12, 2025 | 3 min read Twitter LinkedIn Facebook Email Print ROCHESTER, Minn.--(BUSINESS WIRE)--RION, a clinical-stage regenerative medicine company at the forefront of … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin